{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:06:48Z","timestamp":1788876408141,"version":"build-2803163510"},"reference-count":25,"publisher":"American Chemical Society (ACS)","issue":"35","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic kidney disease (CKD), a heterogeneous disorder with limited therapeutic options, is often complicated by drug-induced nephrotoxicity from aminoglycosides, such as gentamicin (GM). Nintedanib (NTD), a tyrosine kinase inhibitor with antifibrotic and anti-inflammatory properties, holds promise but is limited by poor solubility, low bioavailability, and potential systemic toxicity. To overcome these challenges, a nintedanib nanosuspension polymer (NTD-PNP) was developed using polycaprolactone (PCL) to improve solubility, control drug release, and maximize oral bioavailability. Physicochemical classification confirmed spherical, smooth-surfaced nanoparticles with particle sizes of 106.5\u2013154.7 nm, \u03b6-potential of \u22121.39 to +8.86 mV, polydispersity index (PDI) of 0.139\u20130.384, entrapment efficiency of 28.92\u201370.92%, and drug loading of 19.94\u201347.28%. Compared with the free drug, NTD-PNPs displayed superior solubility and prolonged release kinetics. The therapeutic efficacy of NTD-PNPs was evaluated for 28 days in a gentamicin-induced CKD rat model (100 mg\/kg, 21 days). Treatment with NTD-PNPs significantly reduced blood urea nitrogen and creatinine levels, indicating improved renal function. Immunohistochemical analysis further revealed downregulation of fibronectin, \u03b1-SMA, Smad3, and collagen III expression, and histopathology showed a reduction in tubular degeneration, extracellular matrix accumulation, and fibrosis. Collectively, these findings demonstrate that NTD-PNPs enhance the therapeutic index of nintedanib, offering a promising sustained-release nano formulation to mitigate CKD progression.<\/jats:p>","DOI":"10.1021\/acsomega.6c03965","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:13:28Z","timestamp":1788304408000},"page":"52771-52786","source":"Crossref","is-referenced-by-count":0,"title":["Development and\n                    <i>In Vitro<\/i>\n                    \/\n                    <i>In Vivo<\/i>\n                    Characterization of Surface-Modified\nNintedanib-Loaded\nNanoparticles for Enhanced Bioavailability in Chronic Kidney Disease"],"prefix":"10.1021","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0587-2532","authenticated-orcid":true,"given":"V. M.","family":"Prajapati","sequence":"first","affiliation":[{"name":"CSIR-Central Drug Research Institute , , , ,","place":["Lucknow, Uttar Pradesh, India, 226031"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit Deb","family":"Choudhury","sequence":"additional","affiliation":[{"name":"CSIR-Central Drug Research Institute , , , ,","place":["Lucknow, Uttar Pradesh, India, 226031"]},{"name":"Jawaharlal Nehru University , ,","place":["New Delhi, India, 110067"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Kumar","sequence":"additional","affiliation":[{"name":"CSIR-Central Drug Research Institute , , , ,","place":["Lucknow, Uttar Pradesh, India, 226031"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Rathore","sequence":"additional","affiliation":[{"name":"CSIR-Central Drug Research Institute , , , ,","place":["Lucknow, Uttar Pradesh, India, 226031"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gargi","family":"Sharma","sequence":"additional","affiliation":[{"name":"CSIR-Central Drug Research Institute , , , ,","place":["Lucknow, Uttar Pradesh, India, 226031"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tavishi","family":"Singh","sequence":"additional","affiliation":[{"name":"CSIR-Central Drug Research Institute , , , ,","place":["Lucknow, Uttar Pradesh, India, 226031"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara Singh","family":"Farswan","sequence":"additional","affiliation":[{"name":"CSIR-Central Drug Research Institute , , , ,","place":["Lucknow, Uttar Pradesh, India, 226031"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayushman","family":"Singh","sequence":"additional","affiliation":[{"name":"CSIR-Central Drug Research Institute , , , ,","place":["Lucknow, Uttar Pradesh, India, 226031"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramakrishna","family":"Rayiti","sequence":"additional","affiliation":[{"name":"CSIR-Central Drug Research Institute , , , ,","place":["Lucknow, Uttar Pradesh, India, 226031"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shovan","family":"Ghosh","sequence":"additional","affiliation":[{"name":"CSIR-Central Drug Research Institute , , , ,","place":["Lucknow, Uttar Pradesh, India, 226031"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Kumar","sequence":"additional","affiliation":[{"name":"CSIR-Central Drug Research Institute , , , ,","place":["Lucknow, Uttar Pradesh, India, 226031"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajdeep","family":"Guha","sequence":"additional","affiliation":[{"name":"CSIR-Central Drug Research Institute , , , ,","place":["Lucknow, Uttar Pradesh, India, 226031"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind Singh","family":"Kshatri","sequence":"additional","affiliation":[{"name":"CSIR-Central Drug Research Institute , , , ,","place":["Lucknow, Uttar Pradesh, India, 226031"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabi Sankar","family":"Bhatta","sequence":"additional","affiliation":[{"name":"CSIR-Central Drug Research Institute , , , ,","place":["Lucknow, Uttar Pradesh, India, 226031"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. B.","family":"Pant","sequence":"additional","affiliation":[{"name":"Indian Institute of Toxicology and Research , , , ,","place":["Lucknow, Uttar Pradesh, India, 226001"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. K.","family":"Rath","sequence":"additional","affiliation":[{"name":"CSIR-Central Drug Research Institute , , , ,","place":["Lucknow, Uttar Pradesh, India, 226031"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"issue":"10105","key":"2026090809085241000_cit1","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/S0140-6736(17)30788-2","article-title":"Global kidney health\n2017 and beyond: a roadmap for closing gaps in care, research, and\npolicy","volume":"390","author":"Levin","year":"2017","journal-title":"Lancet"},{"issue":"10075","key":"2026090809085241000_cit2","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic Kidney Disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"issue":"11","key":"2026090809085241000_cit3","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of\nthe kidney disease: improving global outcomes 2012 clinical practice\nguideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"2026090809085241000_cit4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology\nof chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney\nInt. Suppl."},{"issue":"6","key":"2026090809085241000_cit5","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1172\/JCI72267","article-title":"Cellular\nand molecular mechanisms in kidney fibrosis","volume":"124","author":"Duffield","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"1","key":"2026090809085241000_cit6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","article-title":"Mechanisms\nof renal fibrosis","volume":"80","author":"Humphreys","year":"2018","journal-title":"Annu. Rev. Physiol."},{"issue":"1","key":"2026090809085241000_cit7","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-024-00765-3","article-title":"The nephroprotective\npotential of selected synthetic compound against gentamicin induced\nnephrotoxicity","volume":"25","author":"Amir","year":"2024","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"2","key":"2026090809085241000_cit8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/ncpneph0076","article-title":"Drug-associated renal\ndysfunction and injury","volume":"2","author":"Choudhury","year":"2006","journal-title":"Nat. Clin. Pract. Nephrol."},{"issue":"4","key":"2026090809085241000_cit9","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1172\/JCI111558","article-title":"Prevention\nof granulocyte-mediated oxidant lung injury in rats by a hydroxyl\nradical scavenger, dimethylthiourea","volume":"74","author":"Fox","year":"1984","journal-title":"J. Clin.\nInvest."},{"issue":"3","key":"2026090809085241000_cit10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ki.1985.39","article-title":"Role of oxygen radicals\nin phorbol myristate acetate-induced glomerular injury","volume":"27","author":"Rehan","year":"1985","journal-title":"Kidney Int."},{"issue":"1","key":"2026090809085241000_cit11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.taap.2007.05.004","article-title":"Glomerular\nnephrotoxicity of aminoglycosides","volume":"223","author":"Marti\u0301nez-Salgado","year":"2007","journal-title":"Toxicol.\nAppl. Pharmacol."},{"issue":"11","key":"2026090809085241000_cit12","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1007\/s13346-022-01148-z","article-title":"Bioavailability enhancement of vitamin\nE TPGS liposomes\nof nintedanib esylate: Formulation optimization, cytotoxicity and\npharmacokinetic studies","volume":"12","author":"Kala","year":"2022","journal-title":"Drug Delivery Transl.\nRes."},{"key":"2026090809085241000_cit13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123644","article-title":"Nintedanib\nsolid lipid\nnanoparticles improve oral bioavailability and ameliorate pulmonary\nfibrosis in vitro and in vivo models","volume":"649","author":"Kaur","year":"2024","journal-title":"Int. J.\nPharm."},{"key":"2026090809085241000_cit14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.polymertesting.2017.01.032","article-title":"Surface-coated polycaprolactone\nnanoparticles with pharmaceutical application: Structural and molecular\nmobility evaluation by TD-NMR","volume":"60","author":"Tavares","year":"2017","journal-title":"Polym. Test."},{"key":"2026090809085241000_cit15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.105233","article-title":"Development and characterization\nof inhaled nintedanib-loaded PLGA nanoparticles using scalable high-pressure\nhomogenization technique","volume":"91","author":"Wang","year":"2024","journal-title":"J. Drug Delivery Sci.\nTechnol."},{"key":"2026090809085241000_cit16","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121020","article-title":"Nanoparticles of naturally\noccurring PPAR-\u03b3 inhibitor betulinic acid ameliorates bone marrow\nadiposity and pathological bone loss in ovariectomized rats via Wnt\/\u03b2-catenin\npathway","volume":"309","author":"Sardar","year":"2022","journal-title":"Life Sci."},{"issue":"3","key":"2026090809085241000_cit17","first-page":"217","article-title":"Kinetic modeling on\ndrug release from controlled drug delivery systems","volume":"67","author":"Dash","year":"2010","journal-title":"Acta Pol. Pharm."},{"issue":"2","key":"2026090809085241000_cit18","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e03451","article-title":"A comparison of models\nfor the analysis of the kinetics of drug release from PLGA-based nanoparticles","volume":"6","author":"Jahromi","year":"2020","journal-title":"Heliyon"},{"issue":"2","key":"2026090809085241000_cit19","doi-asserted-by":"publisher","DOI":"10.1002\/sscp.202200125","article-title":"Development\nof a sensitive\nand selective bioanalytical method of chebulinic acid by liquid chromatography-electrospray\ntandem mass spectrometry and its pharmacokinetic application","volume":"6","author":"Verma","year":"2022","journal-title":"Sep. Sci. Plus"},{"issue":"5","key":"2026090809085241000_cit20","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1631\/jzus.B1100272","article-title":"Relative bioavailability and pharmacokinetic\ncomparison\nof two different enteric formulations of omeprazole","volume":"13","author":"Liu","year":"2012","journal-title":"J. Zhejiang Univ., Sci., B"},{"issue":"6","key":"2026090809085241000_cit21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2026.168278","article-title":"Longitudinal assessment\nactivation of TGF-\u03b21\/pSmad2\/3 signaling promotes hepatocyte\nreprogramming and fibrosis via Oct4, Sox9, and RunX2 in experimentally\ninduced rats","volume":"1872","author":"Yadav","year":"2026","journal-title":"Biochim. Biophys. Acta, Mol. Basis\nDis."},{"issue":"2","key":"2026090809085241000_cit22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/BF00656997","article-title":"Improved\npatch-clamp\ntechniques for high-resolution current recording from cells and cell-free\nmembrane patches","volume":"391","author":"Hamill","year":"1981","journal-title":"Pflugers Arch."},{"issue":"1","key":"2026090809085241000_cit23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0006-3495(98)77782-3","article-title":"Properties of HERG channels\nstably expressed in HEK 293 cells studied at physiological temperature","volume":"74","author":"Zhou","year":"1998","journal-title":"Biophys. J."},{"issue":"9","key":"2026090809085241000_cit24","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s40262-019-00766-0","article-title":"Clinical\nPharmacokinetics\nand Pharmacodynamics of Nintedanib","volume":"58","author":"Wind","year":"2019","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"2026090809085241000_cit25","doi-asserted-by":"publisher","DOI":"10.1007\/s40199-026-00606-0","article-title":"Tableting of nanoparticle-based formulations for oral delivery: Enhancing\nbiopharmaceutical performance","volume":"34","author":"Pen\u0303aloza","year":"2026","journal-title":"Daru, J. Pharm.\nSci."}],"container-title":["ACS Omega"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsomega.6c03965","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/11\/35\/52771\/67547337\/acsomega.6c03965.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/11\/35\/52771\/67547337\/acsomega.6c03965.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:09:01Z","timestamp":1788872941000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/acsodf\/article\/11\/35\/52771\/5343251\/Development-and-In-Vitro-In-Vivo-Characterization"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":25,"journal-issue":{"issue":"35","published-online":{"date-parts":[[2026,8,27]]},"published-print":{"date-parts":[[2026,9,8]]}},"URL":"https:\/\/doi.org\/10.1021\/acsomega.6c03965","relation":{},"ISSN":["2470-1343"],"issn-type":[{"value":"2470-1343","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]}}}